stockhead14h
Gold Digger: The gold M&A deals on the experts’ chess boards
With two juniors entering trading halts, more gold M&A could be coming in 2024. With prices near record highs, 2025 looks ...
stockhead6h
ASX Lunch Wrap: Local market’s good form continues as Brainchip and Droneshield soar
ASX rallies on commodity boost as Brainchip and Droneshield soar, while Aussies may have splashed $1.3B on Boxing Day sales.
stockhead5h
How new, smarter TVs are transforming the Boxing Day Test viewer experience
AI is beginning to influence yet more aspects of regular life, changing how Aussies with the right tech see the Boxing Day ...
stockhead3h
Closing Bell: ASX closes week higher as Appen, Novonix race ahead
ASX rallies on commodity boost with BrainChip and DroneShield leading the charge, but 2025 volatility looms with key risks on ...
stockhead17h
Resources Top 5: Japan’s Sumitomo wades deeper into critical minerals mission
The owner of a fluorspar deposit in northern WA says Japan's Sumitomo could take a 22.5% stake in a $60m JV to develop the ...
stockhead20h
2024 IPO Performers: Which fresh listings stole the stage this year?
Out of 27 IPOs in 2024, two resources plays, an engineering stock, a Mexican food chain and a wool clothing company topped ...
stockhead20h
Biocurious: Behind Race Oncology’s quest to prevent chemo from being worse than the disease
Race Oncology hopes its repurposed drug candidate bisantrene can protect the heart from the dangerous effect of chemotherapy.